- TWD6.89bn
- TWD4.86bn
- TWD1.87bn
- 62
- 31
- 38
- 36
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,455 | 1,641 | 1,577 | 1,691 | 1,865 |
Cost of Revenue | |||||
Gross Profit | 1,267 | 1,358 | 1,322 | 1,462 | 1,596 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,196 | 1,403 | 1,380 | 1,494 | 1,715 |
Operating Profit | 259 | 237 | 197 | 197 | 150 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 476 | 254 | -502 | 221 | 306 |
Provision for Income Taxes | |||||
Net Income After Taxes | 380 | 188 | -563 | 184 | 222 |
Net Income Before Extraordinary Items | |||||
Net Income | 380 | 188 | -563 | 184 | 222 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 380 | 188 | -563 | 184 | 222 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.54 | 2.2 | -7.19 | 2.33 | 2.77 |
Dividends per Share |